Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT04983095 · RECRUITING

Trial details

NCT number: NCT04983095
Sponsor: Karin Soderkvist
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Radiation Therapy Positron-Emission Tomography

Start date: 2021-10-27
Primary completion: 2031-12-31
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.